These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33358350)

  • 1. Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study.
    Lawall H; Bramlage P; Gorath M; Wittig T
    Eur J Vasc Endovasc Surg; 2021 Mar; 61(3):457-465. PubMed ID: 33358350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication.
    Walker SR; Tennant S; MacSweeney ST
    J Vasc Surg; 1998 Nov; 28(5):895-900. PubMed ID: 9808859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
    Russell KS; Yates DP; Kramer CM; Feller A; Mahling P; Colin L; Clough T; Wang T; LaPerna L; Patel A; Lawall H; Shennak MM; Fulmer J; Nikol S; Smith WB; Müller OJ; Ratchford EV; Basson CT
    Vasc Med; 2019 Oct; 24(5):414-421. PubMed ID: 31277561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study.
    Perrotta A; Serrao M; Tassorelli C; Arce-Leal N; Guaschino E; Sances G; Rossi P; Bartolo M; Pierelli F; Sandrini G; Nappi G
    Eur J Pain; 2011 May; 15(5):482-90. PubMed ID: 20965755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.
    Omarjee L; Le Pabic E; Custaud MA; Fontaine C; Locher C; Renault A; Jaquinandi V; Azzola V; Barbeau-Terrier C; Laporte I; Ripoche M; Onillon Y; Chretien JM; Daniel V; Chao de la Barca JM; Homedan C; Reynier P; Abraham P; Mahé G
    Vascul Pharmacol; 2019; 118-119():106563. PubMed ID: 31152977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study.
    Besnier F; Sénard JM; Grémeaux V; Riédel M; Garrigues D; Guiraud T; Labrunée M
    Trials; 2017 Aug; 18(1):373. PubMed ID: 28797281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate.
    Carapeti EA; Kamm MA; McDonald PJ; Chadwick SJ; Melville D; Phillips RK
    Gut; 1999 May; 44(5):727-30. PubMed ID: 10205213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
    J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease.
    Park SY; Pekas EJ; Headid RJ; Son WM; Wooden TK; Song J; Layec G; Yadav SK; Mishra PK; Pipinos II
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H456-H467. PubMed ID: 32706261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Actovegin in the treatment of intermittent claudication: results of an international, multicenter, placebo-controlled, randomized, phase IIIb clinical trial (APOLLO).
    Suchkov IA; Mzhavanadze ND; Bogachev VY; Bokuchava M; Kuznetsov MR; Lukyanov YV; Kelimbetov R; Pang H; Araslanov SA
    Int Angiol; 2022 Oct; 41(5):405-412. PubMed ID: 36264097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures.
    Scholefield JH; Bock JU; Marla B; Richter HJ; Athanasiadis S; Pröls M; Herold A
    Gut; 2003 Feb; 52(2):264-9. PubMed ID: 12524411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal shockwave therapy for intermittent claudication: Medium-term outcomes from a double-blind randomised placebo-controlled pilot trial.
    Green JL; Harwood AE; Smith GE; Das T; Raza A; Cayton T; Wallace T; Carradice D; Chetter IC
    Vascular; 2018 Oct; 26(5):531-539. PubMed ID: 29722640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous alprostadil treatment compared to oral pentoxifylline treatment in outpatients with intermittent claudication - results of a randomised clinical trial.
    Schellong SM; von Bilderling P; Gruss JD; Lawall H; Grieger F; Ney U; Bramlage P; Diehm C; Bentz J
    Vasa; 2017 Aug; 46(5):403-405. PubMed ID: 28558485
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Remote Ischemic Conditioning and Glyceryl Trinitrate on Perioperative Myocardial Injury in Cardiac Bypass Surgery Patients: Rationale and Design of the ERIC-GTN Study.
    Hamarneh A; Sivaraman V; Bulluck H; Shanahan H; Kyle B; Ramlall M; Chung R; Jarvis C; Xenou M; Ariti C; Cordery R; Yellon DM; Hausenloy DJ
    Clin Cardiol; 2015 Nov; 38(11):641-6. PubMed ID: 26412308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol.
    Labs KH; Nehler MR; Roessner M; Jaeger KA; Hiatt WR
    Vasc Med; 1999; 4(4):239-46. PubMed ID: 10613628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.